Delivery Order SPE2DP18D0006-SPE2DP19F0724
Award Date 11/15/18
Potential Completion Date 11/30/18
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The order was issued under contract SPE2DP18D0006 and has a firm fixed price ceiling value of $17,193.60. The order was awarded on October 16, 2018, with a performance completion date of November 5, 2018. The contract does not have a set-aside designation. GlaxoSmithKline has received multiple federal contract awards and grants...
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC for the provision of flu vaccines. The $39,180 firm fixed price contract has a period of performance through September 30, 2024. There is no set-aside designation for this award. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has provided a range of vaccines and antiviral medications to U.S. government agencies through federal...
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0456, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The contract is a firm fixed-price Delivery Order with a ceiling value of $173,368.80 and a period of performance ending on November 8, 2018. The contract was not set aside for any specific business designation. Glaxosmithkline, LLC has provided a range of pharmaceutical goods and...
- This federal contract award, valued at $9,033,542.56, was issued by the Defense Department's Medical Supply Chain agency to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of influenza virus vaccines. The contract has a firm fixed price structure and an ultimate completion date of October 17, 2016. It is not designated as a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and services to various federal agencies, including vaccines, antiviral...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
- This is a delivery order issued by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, for the provision of the influenza vaccine FLUARIX. The contract has a firm fixed price of $107,745.00 and a completion date of December 31, 2024. The contract is not set aside for any specific business category. Glaxosmithkline has a history of providing a range of pharmaceutical products, including vaccines, antiviral medications,...
- This is a firm fixed price delivery order issued by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, for the provision of $223,344.00 worth of quadrivalent influenza vaccines in pre-filled syringes. The order has an October 15, 2020 completion date and was awarded on March 24, 2020. There is no set-aside designation indicated. Glaxosmithkline has a history of providing a range of pharmaceutical products,...